{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28749403",
  "DateCompleted": {
    "Year": "2018",
    "Month": "04",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.4103/ijmr.IJMR_1427_15"
    ],
    "Journal": {
      "ISSN": "0971-5916",
      "JournalIssue": {
        "Volume": "145",
        "Issue": "3",
        "PubDate": {
          "Year": "2017",
          "Month": "Mar"
        }
      },
      "Title": "The Indian journal of medical research",
      "ISOAbbreviation": "Indian J Med Res"
    },
    "ArticleTitle": "HIV-malaria interactions in North-East India: A prospective cohort study.",
    "Pagination": {
      "StartPage": "387",
      "EndPage": "394",
      "MedlinePgn": "387-394"
    },
    "Abstract": {
      "AbstractText": [
        "The interactions between HIV and malaria co-infection have been shown to influence each other in their clinical outcomes in Sub-Saharan Africa. This study was carried out in the two States of north east India endemic for both HIV and malaria infections, to study the interactions between the two diseases in the HIV-infected population.",
        "In this prospective study, a total of 333 HIV-infected individuals were followed up for a period of 6-18 months in Mizoram and Manipur during 2010-2011. The study assessed the changes in viral load and also the therapeutic efficacy of artesunate plus sulphadoxine-pyrimethamine (AS+SP) combination therapy in HIV-infected and HIV-uninfected individuals with Plasmodium falciparum malaria.",
        "Viral load in HIV-infected malaria patients on day zero (D0) ranged from 1110 to 147,000 copies/ml. The log transformation of the geometric means of HIV viral loads revealed no significant difference on different days of follow up. There was 100 per cent adequate clinical and parasitological response (ACPR) after treating with artemisinin based combination therapy (ACT) both in HIV-infected and HIV-uninfected P. falciparum-positive individuals. Similarly, chloroquine showed 100 per cent ACPR in P. vivax HIV-infected individuals.",
        "The study showed no significant increase in HIV viral load in malaria cases. All HIV-infected and HIV-uninfected P. falciparum malaria-positive cases responded to the treatment with 100 per cent ACPR."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Regional Medical Research Centre (ICMR), Dibrugarh, India."
          }
        ],
        "LastName": "Mohapatra",
        "ForeName": "Pradhyumn K",
        "Initials": "PK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Civil Hospital, Aizawl, India."
          }
        ],
        "LastName": "Pachuau",
        "ForeName": "Elsa",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Community Medicine, Regional Institute of Medical Sciences, Imphal, India."
          }
        ],
        "LastName": "Kumar",
        "ForeName": "Chandra",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Regional Medical Research Centre (ICMR), Dibrugarh, India."
          }
        ],
        "LastName": "Borkakoty",
        "ForeName": "Biswajit",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Civil Hospital, Aizawl, India."
          }
        ],
        "LastName": "Zomawia",
        "ForeName": "Eric",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Community Medicine, Regional Institute of Medical Sciences, Imphal, India."
          }
        ],
        "LastName": "Singh",
        "ForeName": "Achouba",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India."
          }
        ],
        "LastName": "Walia",
        "ForeName": "Kamini",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India."
          }
        ],
        "LastName": "Arora",
        "ForeName": "Rashmi",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Regional Medical Research Centre (ICMR), Dibrugarh, India."
          }
        ],
        "LastName": "Mahanta",
        "ForeName": "Jagdish",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India."
          }
        ],
        "LastName": "Subbarao",
        "ForeName": "Sarala K",
        "Initials": "SK"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "India",
    "MedlineTA": "Indian J Med Res",
    "NlmUniqueID": "0374701",
    "ISSNLinking": "0971-5916"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antimalarials"
    },
    {
      "RegistryNumber": "886U3H6UFF",
      "NameOfSubstance": "Chloroquine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antimalarials"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Chloroquine"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "parasitology",
        "virology"
      ],
      "DescriptorName": "Coinfection"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Drug Resistance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "parasitology",
        "virology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "parasitology",
        "virology"
      ],
      "DescriptorName": "Malaria, Falciparum"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "parasitology",
        "virology"
      ],
      "DescriptorName": "Malaria, Vivax"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Plasmodium falciparum"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Viral Load"
    }
  ],
  "CoiStatement": "<b><i>Conflicts of Interest:</i></b> None."
}